RTL Info article
"Champignons hallucinogènes, ecstasy, LSD: faut-il permettre leur utilisation pour traiter les troubles psychiatriques?"
Trippen als therapie
"Nieuw onderzoek toont aan dat deze geestverruimende
middelen helpen bij ernstige psychische problemen, zoals een
depressie of posttraumatische stressstoornis."
PSBE informs the medical world
To view this article in Dutch, French or English, first choose your language and then click "Read more".
"We zijn het aan hulpbehoevenden verplicht om te kijken hoe substanties met een wetenschappelijk bewezen nut in de behandeling van mentale ziektes gedecriminaliseerd kunnen worden"
"We think this could be a treatment for a number of depressive disorders besides major depression, including PTSD, treatment-resistant depression, obsessive-compulsive disorder, and possibly some types of substance abuse.”
"The denial of access of a proven therapy to millions of patients with chronic mental illnesses is horrific. It's the worst censorship of access of medicine to people who need it. Probably in the history of the world." - David Nutt
"Our grandchildren will look back on this moment and ask why a substance that had the potential to solve such large problems in society was ever banned in the first place."
" For me personally, the study represents a milestone for German psychiatry, from which I expect not only impulses for treatment research, but also insights into the nature of mental illness and the foundations of consciousness. "
“The magnitude of the effect we saw was about four times larger than what clinical trials have shown for traditional antidepressants on the market,”
" Oregon became the first state in the nation to decriminalize the possession of all illegal drugs and also legalize the use of psilocybin—the active ingredient in hallucinogenic mushrooms—for mental-health treatment, after voters passed a pair of ballot measures this week. "
" This is the first known time such an exemption has been granted specifically for the consumption of mushrooms, according to TheraPsil, a nonprofit organization that advocates for psychedelic therapy in end-of-life care in Canada. "